| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 80, 3223-3226, Copyright © 1995 by Endocrine Society
ARTICLES |
B Delhougne, C Deneux, R Abs, P Chanson, H Fierens, P Laurent-Puig, I Duysburgh, A Stevenaert, A Tabarin and J Delwaide
Department of Gastroenterology, University of Liege, Belgium.
Patients with acromegaly are reported to be at risk of developing adenomatous colonic polyps, which are considered to be preneoplastic lesions. This assumption is, however, usually drawn from results obtained in rather small series of patients or without a control group. We, therefore, undertook a prospective colonoscopic and pathological study comprising 103 acromegalic patients and 138 nonacromegalic control subjects referred for irritable bowel syndrome. The prevalence of adenomatous colonic polyps was significantly increased in acromegalic patients compared to that in control subjects (22.3% vs. 8.0%; P = 0.0024). The significance was similarly present in male acromegalic patients (28.6% vs. 5.5% in male control subjects; P = 0.0026), but was absent in female acromegalic patients. The prevalence of colonic polyps was also significantly increased in the group of acromegalic patients under 55 yr of age (20.0% vs. 3.0% in the control group of the same age; P = 0.0026). Other characteristics of adenomatous colonic polyps in acromegaly were the multiplicity and the presence proximal to the splenic flexure. No difference in the duration of acromegaly was found between patients with or without adenomatous polyps. The prevalence of hyperplastic colonic polyps was also significantly increased to 24.3% in acromegalic patients vs 4.4% in control subjects (P < 0.001). In conclusion, in view of the increased incidence of adenomatous colonic polyps, colonoscopy should be part of the follow-up examination in acromegaly.
This article has been cited by other articles:
![]() |
A. Colao, R. Pivonello, R. S. Auriemma, M. Galdiero, D. Ferone, F. Minuto, P. Marzullo, and G. Lombardi The Association of Fasting Insulin Concentrations and Colonic Neoplasms in Acromegaly: A Colonoscopy-Based Study in 210 Patients J. Clin. Endocrinol. Metab., October 1, 2007; 92(10): 3854 - 3860. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Pazaitou-Panayiotou, T. Kelesidis, I. Kelesidis, A. Kaprara, J. Blakeman, I. Vainas, A. Mpousoulegas, C. J Williams, and C. Mantzoros Growth hormone-binding protein is directly and IGFBP-3 is inversely associated with risk of female breast cancer Eur. J. Endocrinol., February 1, 2007; 156(2): 187 - 194. [Abstract] [Full Text] [PDF] |
||||
![]() |
L A Thomas, M J Veysey, G M Murphy, D Russell-Jones, G L French, J A H Wass, and R H Dowling Octreotide induced prolongation of colonic transit increases faecal anaerobic bacteria, bile acid metabolising enzymes, and serum deoxycholic acid in patients with acromegaly Gut, May 1, 2005; 54(5): 630 - 635. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Colao, D. Ferone, P. Marzullo, and G. Lombardi Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management Endocr. Rev., February 1, 2004; 25(1): 102 - 152. [Abstract] [Full Text] [PDF] |
||||
![]() |
P J Jenkins and P D Fairclough Screening guidelines for colorectal cancer and polyps in patients with acromegaly Gut, October 1, 2002; 51(90005): v13 - 14. [Full Text] [PDF] |
||||
![]() |
S. Melmed CLINICAL PERSPECTIVE: Acromegaly and Cancer: Not a Problem? J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 2929 - 2934. [Full Text] [PDF] |
||||
![]() |
P. J. Jenkins and M. Besser CLINICAL PERSPECTIVE: Acromegaly and Cancer: A Problem J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 2935 - 2941. [Full Text] [PDF] |
||||
![]() |
P. J. Jenkins, V. Frajese, A-M. Jones, C. Camacho-Hubner, D. G. Lowe, P. D. Fairclough, S. L. Chew, A. B. Grossman, J. P. Monson, and G. M. Besser Insulin-Like Growth Factor I and the Development of Colorectal Neoplasia in Acromegaly J. Clin. Endocrinol. Metab., September 1, 2000; 85(9): 3218 - 3221. [Abstract] [Full Text] |
||||
![]() |
A. G. Renehan, P. Bhaskar, J. E. Painter, S. T. ODwyer, N. Haboubi, J. Varma, S. G. Ball, and S. M. Shalet The Prevalence and Characteristics of Colorectal Neoplasia in Acromegaly J. Clin. Endocrinol. Metab., September 1, 2000; 85(9): 3417 - 3424. [Abstract] [Full Text] |
||||
![]() |
P J JENKINS, G M BESSER, and P D FAIRCLOUGH Colorectal neoplasia in acromegaly Gut, May 1, 1999; 44(5): 585 - 587. [Full Text] [PDF] |
||||
![]() |
S. M. Orme, R. J. Q. McNally, R. A. Cartwright, and P. E. Belchetz Mortality and Cancer Incidence in Acromegaly: A Retrospective Cohort Study J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2730 - 2734. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |